Studying two very different viruses is helping this virologist develop new strategies for more potent antiviral treatments
March 30, 2026
March 30, 2026
NEW YORK, March 30 -- Rockefeller University posted the following Q&A involving virologist Theodora Hatziioannou:
* * *
Studying two very different viruses is helping this virologist develop new strategies for more potent antiviral treatments
*
Beyond both being viruses, HIV-1 and SARS-CoV-2 don't seem to have a lot in common. HIV-1 is a retrovirus that integrates with its host's DNA for life and can be passed down from mother to . . .
* * *
Studying two very different viruses is helping this virologist develop new strategies for more potent antiviral treatments
*
Beyond both being viruses, HIV-1 and SARS-CoV-2 don't seem to have a lot in common. HIV-1 is a retrovirus that integrates with its host's DNA for life and can be passed down from mother to . . .